Matthew Lanktree
The Clinical Research Laboratory and Biobank- Genetic and Molecular Epidemiology Laboratory (CRLB-GMEL) recently hosted the Second Annual Multiomics Day at McMaster University, bringing together more than 80 researchers.
Aimed at showcasing the potential of Multiomics and its role in driving research breakthroughs, the event featured presentations by experts:
- PHRI Scientist Matthew Lanktree discussed spatial Multi-Omics in kidney disease research, exploring how genomics, transcriptomics, and proteomics reveal new therapeutic targets.
- Caitlyn Vlasschaert, from Queen’s University, delved into ‘Clonal hematopoiesis of indeterminate potential (CHIP)’, shedding light on its role in age-related chronic diseases, particularly in cardiovascular and kidney diseases.
- Shanmini Ayyadury, from the University of Toronto, presented ‘Understanding the functional relevance of GBM architecture through pattern recognition,’ focusing on a multiomics approach to decipher the principles governing GBM evolution.
We’re off to a great start at @GMEL_McMaster 2nd Annual Multiomics Day! pic.twitter.com/LNis4JaGwd
— Caitlyn Vlasschaert (@DrFlashHeart) November 30, 2023
Next is Shana Lamers from @OlinkProteomics, who facilitates Olink analyses in 🇨🇦.
She tells us about how Olink technology (dual antibody recognition approach) affords great specificity in proteome quantification. pic.twitter.com/DmsMBk3ucv
— Caitlyn Vlasschaert (@DrFlashHeart) November 30, 2023
Operating for more than 35 years, CRLB-GMEL has supported 100+ PHRI studies, offering a spectrum of laboratory services, including biobanking, proteomics, and metabolomics.
The event was sponsored by Olink, 10X Genomics, and Illumina.
